Divergent clinical and immunologic outcomes based on STK11 co-mutation status in resectable KRAS-mutant lung cancers following neoadjuvant immune checkpoint blockade
Ontology highlight
ABSTRACT: Divergent clinical and immunologic outcomes based on STK11 co-mutation status in resectable KRAS-mutant lung cancers following neoadjuvant immune checkpoint blockade
PROVIDER: PRJNA1177414 | ENA |
REPOSITORIES: ENA
ACCESS DATA